eClinical Technology and Industy News

Rocket VR Announces New Study Exploring The Impact of Virtual Reality Therapeutics on Chronic Pain in Cancer Patients

Research with renowned oncology expert Dr. Linda Carlson will assess feasibility of a virtual reality guided mindfulness program

Excerpt from the Press Release:

BOSTON, May 5, 2022 /PRNewswire/ — Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is pleased to announce a new study in partnership with Dr. Linda Carlson, Enbridge Research Chair in Psychosocial Oncology at the University of Calgary Cumming School of Medicine. The first-of-its-kind study will assess the feasibility of a virtual reality guided mindfulness (VRGM) intervention program in adult cancer patients with chronic cancer-related pain (CRP).

CRP has a significant negative impact on quality of life. The prevalence of CRP has been estimated at 30–50% in patients undergoing cancer treatment and more than 70% in patients with advanced disease. Mindfulness is hypothesized to mitigate chronic CRP by regulating both physical and emotional resistance to pain. Virtual reality provides an immersive and engaging environment which may enhance one’s focused attention to present moment experiences, potentially making mindfulness easier and more effective for individuals with chronic pain.

“Our team at Rocket VR believes virtual reality therapies have the potential to change the way cancer care is delivered,” said Sid Desai, CEO and Co-Founder of Rocket VR Health. “We are passionate about accelerating virtual reality research to address the unmet health needs of cancer patients and survivors. Collaborating with leading cancer centers and experts like Dr. Carlson will bring us one step closer to developing leading evidence-based digital therapeutics for cancer patients and survivors.”

Fifteen cancer survivors will be enrolled in a six-week, home-based intervention that consists of approximately 15 minutes of daily VRGM practice. Participants will be assessed on psychosocial outcome measures before and after the study, including pain, sleep, depressive and anxiety symptoms, fatigue, quality of life, and mindfulness.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary Data Management

Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives